Website Content From This Issue

Website Content from This Issue

Coronavirus

Personal Reflections on Five Years of COVID-19

January 6, 2025

Bioprocessing

Major Trends in Cell and Gene Therapy

January 6, 2025

Artificial Intelligence

2025 Trends: Organoids

January 6, 2025

Insights

2025 Trends: Multiomics

January 6, 2025

Artificial Intelligence

2025 Trends: NGS

January 6, 2025

A-Lists

Top 25 Biotech Companies Heading Into 2025

January 6, 2025

Artificial Intelligence

AI Accelerates and Expands Drug Development

January 6, 2025

Drug Discovery

Automation in Cell Line Development for Biotherapeutics: Current Trends and Challenges

January 6, 2025

Insights

Sorting Technologies Advance Cell-by-Cell

January 6, 2025

Drug Discovery

Mitochondrial Toxicity Early Alert System

January 3, 2025

Artificial Intelligence

Home Cage AI-Monitoring

January 3, 2025

New Products

Automated Mass Photometry Analysis Software

January 3, 2025

New Products

NGS Panel for Chronic Lymphocytic Leukemia Insights

January 3, 2025

New Products

Immune Profiling Kit

January 3, 2025

New Products

Flammable Storage Cabinet

January 3, 2025

Insights

Automated Clone Screening System

January 3, 2025

New Products

Single-Cell Protein Profiling Solution

January 3, 2025

OMICs

A Cost-Effective Single-Cell Workflow Advances Holistic Biological Views

January 2, 2025

Bioprocessing

Accelerating Bispecific Antibody Discovery: From Antigens to Lead Panels in Just Four Months

January 2, 2025

Artificial Intelligence

Insilico Details AI-Designed IBD Candidate’s Path to Nomination

December 11, 2024

Infectious Diseases

Single Influenza Mutation Could Enable Human-to-Human Transmission

December 10, 2024

Artificial Intelligence

AI Drug Discovery Dataset Tops 100M Cells in Vevo, Parse Partnership

December 6, 2024

Cancer

Tumors Have a Taste for Fructose, If It’s Transformed by the Liver

December 4, 2024

Drug Discovery

Alzheimer’s Study Shows Ketone Bodies Help Clear Misfolded Proteins

December 2, 2024

GEN Edge

Going Public: Doudna’s Dream Team Launches Groundbreaking Sickle Cell Trial

December 2, 2024